Veripath, Inc. v. Didomi
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit
VERIPATH, INC., Plaintiff-Appellant
v.
DIDOMI,
Defendant-Appellee
2020-1777
Appeal from the United States District Court for the Southern District of New York in No. 1:19-cv-01702-GBD, Judge George B. Daniels.
Decided: February 8, 2021
JONATHAN K. WALDROP, Kasowitz Benson Torres LLP, Redwood Shores, CA, for plaintiff-appellant. Also represented by HEATHER KIM.
CHARLES R. MACEDO, Amster Rothstein & Ebenstein LLP, New York, NY, for defendant-appellee. Also represented by CHRISTOPHER LISIEWSKI.
Before LOURIE, CHEN, and HUGHES, Circuit Judges.
2 VERIPATH, INC. v. DIDOMI
LOURIE, Circuit Judge.
VeriPath, Inc. (“VeriPath”) appeals from a decision of the United States District Court for the Southern District of New York holding that the claims of U.S. Patent 10,075,451 (“the ’451 patent”) are ineligible for patent under 35 U.S.C. § 101. VeriPath, Inc. v. Didomi, No. 19 CIV. 1702 (GBD), 2020 WL 1503687 (S.D.N.Y. Mar. 30, 2020) (“Decision”). Because we agree with the district court that the patent claims patent-ineligible subject matter, we affirm .
BACKGROUND
VeriPath owns the ’451 patent, which is generally directed to a data privacy system. ’451 patent, Abstract. The patent describes that users can use mobile device applications to “socialize, bank, shop, [and] navigate.” Id. col. 1 ll. 25–27. However, as users interact with the applications, “information about [their] activities or status may be collected automatically.” Id. col. 1 ll. 38–41. The patent states that “[b]ecause of the sensitivity of this personal information , many states and countries” have enacted laws requiring companies that collect such data to (1) present users with a specific privacy disclosure explaining how their personal information will be used and (2) obtain the users’ consent before the information is collected. Id. col 1 ll. 51–55. We are told that the laws governing privacy disclosures and consent requirements can differ from locality to locality, requiring companies to present and collect different privacy disclosures and consents based upon the users ’ location. See id. col. 2 ll. 1–13.
The patent purports to address the drawbacks “of current data collection/privacy schemes by providing an improved , more transparent opt-in process.” Id. col. 2 ll. 29– 31. Specifically, the patent describes an “arrangement [that] allows a component of an application (e.g., a mobile app), in conjunction with other components of a distributed system, to determine what information is to be collected
VERIPATH, INC. v. DIDOMI 3
from a user, how that information will be used, and what permissions are required from that user for that user.” Id. col. 2 ll. 29–36. “In some embodiments, the user may be presented with certain offers in exchange for the user’s consent to a proposed use of certain personal information.” Id. col. 2 ll. 46–48.
Claim 1, which is representative of the claims before us, reads as follows:
1. A method for controlling access to a user’s personal information comprising: providing a software component for inclusion in an application, the software component having an application programming interface (API); obtaining, from the application executing on a device of a user of the application, personal information about the user of the application, the personal information obtained via the API by the software component executing on the device; identifying the type of the obtained personal information ; determining, based on at least the type of obtained personal information, a required permission from the user for at least one proposed use of the obtained personal information; presenting, to the user, a first offer to provide access to at least one enhanced function of the application in exchange for the required permission; and responsive to the user providing the required permission , providing the user with access to the at least one enhanced function of the application.
Id. col. 16 ll. 7–28.
VeriPath sued Didomi, asserting that Didomi had infringed “at least claim 1 of the ’451 Patent.” J.A. 276.
4 VERIPATH, INC. v. DIDOMI
Didomi then filed a motion to dismiss the complaint for failure to state a claim pursuant to Federal Rule of Civil Procedure 12(b)(6), asserting that the claims of the ’451 patent are ineligible for patent under 35 U.S.C. § 101. See J.A. 553–77.
The district court considered the claims under the Supreme Court’s two-step Alice framework for determining patent eligibility. At Alice step one, the court observed that claim 1 of the patent is directed to “the abstract idea of granting permission to access personal information in exchange for enhanced functionality via the API, a routine piece of software.” Decision, 2020 WL 1503687, at *3. At Alice step two, the court determined that claim 1 lacks an inventive concept sufficient to convert the abstract concept into a patent-eligible application. Id. at *4. Additionally, the court asserted that the dependent claims are also ineligible because they are “considerably analogous to claim 1 and suffer from similar defects.” Id. Having concluded that the claims are ineligible for patent under § 101, the court granted Didomi’s motion to dismiss. Id. at *5. Veri- Path appealed to this court. We have jurisdiction pursuant to 28 U.S.C. § 1295(a)(1).
DISCUSSION
We review the grant of a motion to dismiss under the law of the regional circuit. OIP Techs., Inc. v. Amazon.com, Inc., 788 F.3d 1359, 1362 (Fed. Cir. 2015) (citing K–Tech Telecomms., Inc. v. Time Warner Cable, Inc., 714 F.3d 1277, 1282 (Fed. Cir. 2013)). In the Second Circuit, “grant of a motion to dismiss is reviewed de novo to determine whether the claim is plausible on its face, accepting the material factual allegations in the complaint and drawing all reasonable inferences in favor of the plaintiff.” Ottah v. Fiat Chrysler, 884 F.3d 1135, 1141 (Fed. Cir. 2018) (citing Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009)); Bascuñan v. Elsaca, 927 F.3d 108, 116 (2d Cir. 2019).
VERIPATH, INC. v. DIDOMI 5
Patent eligibility under § 101 is an issue of law that may contain underlying issues of fact. See Berkheimer v. HP Inc., 881 F.3d 1360, 1365 (Fed. Cir. 2018). We review the district court’s ultimate conclusion on patent eligibility de novo. Id. To determine whether a patent claims eligible subject matter, we follow the Supreme Court’s familiar two-step framework. See Alice Corp. v. CLS Bank Int’l, 573 U.S. 208, 217 (2014); Mayo Collaborative Servs. v. Prometheus Labs., Inc., 566 U.S. 66, 70–73 (2012). First, we determine whether the claims are directed to a law of nature, natural phenomenon, or abstract idea. See Alice, 573 U.S. at 217. If so, we proceed to the second step and determine whether the claims nonetheless include an “inventive concept ” sufficient to “‘transform the nature of the claim’ into a patent-eligible application.” Id. (quoting Mayo, 566 U.S. at 72, 78). To recite an “inventive concept,” at step two, a patent must do more than recite an abstract idea “while adding the words ‘apply it.’” Id. at 221 (quoting Mayo, 566 U.S. at 72). “[S]imply appending conventional steps, specified at a high level of generality, to laws of nature, natural phenomena, and abstract ideas cannot make those laws, phenomena, and ideas patentable.” Mayo, 566 U.S. at 82.
Free access — add to your briefcase to read the full text and ask questions with AI
Veripath, Inc. v. Didomi (Veripath, Inc. v. Didomi) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.